CARDIOVASCULAR
ENGINEERING

Official Publication of the World Artificial Organ, Immunology and Transplantation Society (WAITS)

Volume 10, 2005, No 1

The Burden of Heart Disease in Canada – What are the Perspectives for the Future Development?
J. G. Fodor, K. B. Adamo

The steady decline in cardiovascular disease (CVD) mortality in Canada over the past three decades appears to be primarily due to improved interventional clinical procedures, advancement in pharmacological therapy and, to a lesser extent, primary prevention. This decline in mortality has resulted in increased CVD prevalence and in turn to increased demand on health care services. High priority should be given to development of new treatment modalities such as the artificial heart and left ventricular assist devices.

(CVE. 2005; 10 (1): 23-25)

Key words: cardiovascular disease, mortality, interventional clinical procedure, pharmacological therapy

K. B. Adamo, M.D.
University of Ottawa Heart Institute
40 rue Ruskin Street
Ottawa KIY 4W7, Ontario
Canada
E-mail: kadamo@ottawaheart.ca